Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy

Song, J., Morgan, A. A., Ahn, J., Li, W. F., Chang, Y., Chang, Y.-C., Fahimuddin, M., Chi, K.-Y., Wu, L. W., & Chiang, C.-H. (2025). Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy. Immunotherapy, 17(6), 419–424. https://doi.org/10.1080/1750743x.2025.2501922
Authors:
Junmin Song
Ahmed Ashraf Morgan
Jaeun Ahn
Wing Fai Li
Yu Chang
Yu-Cheng Chang
Muhammad Fahimuddin
Kuan-Yu Chi
Lawrence W Wu
Cho-Han Chiang
Affiliated Authors:
Lawrence W Wu
Columbia Affiliation:
Subjects:
Stomach Neoplasms (MeSH)
Immune Checkpoint Inhibitors (MeSH)
Venous Thromboembolism (MeSH)
Author Keywords:
khorana risk score
gastric cancer
immune checkpoint inhibitors
thrombosis
venous thromboembolism
elink
Publication Type:
Article
Unique ID:
10.1080/1750743x.2025.2501922
PMID:
40336190
DOI:
10.1080/1750743x.2025.2501922
Journal:
Immunotherapy
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: